University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...
It allows a memory to be actively retained for a few seconds. Certain conditions, such as schizophrenia or depression, as well as ADHD, impair working memory. Those affected lose track in ...
In 2010, neuroscientist and former Eli Lilly research leader Steve Paul started a company that he hoped would spark a revolution in drug discovery built around a class of compounds dubbed ...